Intimation of the Certificate dated July 10, 2025, received from RTA under Regulation 74(5) of SEBI (DP) Regulations, 2018
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has submitted to BSE a certificate dated July 10, 2025, issued by its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime). The certificate is filed in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025. It confirms that physical share certificates received from depository participants for dematerialisation during the quarter were duly accepted or rejected, that the underlying securities are listed on the stock exchanges, and that cancelled certificates were mutilated after verification with the registered holder updated in the register of members within prescribed timelines. The intimation was signed by Chandni Maru, Company Secretary and Compliance Officer.
This is a routine, procedural compliance filing with no material impact on the company's financials, operations, or shareholder value. It does not signal any corporate action, capital change, or business event.